Pre-eclampsia agent gives good birth outcomes

Taking magnesium sulphate during pregnancy reduces the risk of pre-eclampsia seizure without affecting the unborn child’s health.

A two-year follow-up of 3,000 women and their children showed that neither had an increased risk of death of disability because of gestational magnesium sulphate supplements.

The study involved over 8,000 pregnant women with pre-eclampsia who were assigned to receive magnesium sulphate or placebo; magnesium sulphate halved the risk of eclampsia.

Questionnaires on maternal and child health showed little difference in outcomes. In the magnesium sulphate group, 1.3 per cent had neurosensory disability, compared with 1.9 per cent in the placebo group.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in